Long-acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice
- PMID: 35903882
- PMCID: PMC9334859
- DOI: 10.1002/jia2.25963
Long-acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice
References
-
- World Health Organization (WHO) . Guidance on oral pre‐exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. Geneva: WHO; 2012. - PubMed
-
- Joint United Nations Programme on HIV/AIDS (UNAIDS) . 2021 UNAIDS Global AIDS Update — confronting inequalities — lessons for pandemic responses from 40 years of AIDS. Geneva: UNAIDS; 2021.
-
- World Health Organization (WHO) . Differentiated and simplified pre‐exposure prophylaxis for HIV prevention: update to WHO implementation guidance. Geneva: WHO; 2022.
-
- World Health Organization (WHO) . Consolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach, 2021 update. Geneva: WHO; 2021. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical